New drug launches are complicated, costly and inherently inefficient. The breadth of people, processes and technologies required to prep for commercial launch is staggering, and managing multiple project plans and third parties creates process inefficiencies and program management complexity.
RSM professionals understand—through firsthand experience—the challenges of launching a new drug in market. That’s why we’ve developed an integrated launch planning solution—a portfolio of services and technologies designed to reduce launch complexity, cost, and time, enabling you to focus on what matters most: the science.
Our integrated launch planning team is made up of experienced consultants who not only have a deep understanding of critical functional areas, but also appreciate the importance of coordinating launch plans to ensure success. The key: a single point of contact for the services that support your critical constituents—including finance, legal, commercial, market access, compliance and operations—throughout the launch process.
Simplify your launch and maximize your success
RSM’s consulting team consolidates all your service needs into one plan of action with a comprehensive, collaborative strategy and execution across several key business functions. Our experienced advisors know the life sciences industry from preclinical through commercialization, and we utilize effective program governance for each step in the launch process. Whether this is the first time you’ve launched a drug, you’re entering the U.S. for the first time and need extensive support, or you’re experienced and need to supplement existing internal expertise, we can deliver the efficient solutions you need.
If you need ongoing post-launch support, our team can seamlessly transition you into any of our operational and consulting strategies, including revenue contract management, a managed services offering that addresses government pricing, gross-to-net, market access and launch needs.
